Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Wasmuth

Showing results (91-100 of 104) with videos related to

Pageof 11
Sort By:
Hepatology (Baltimore, Md.)|February 18, 2010
CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosisMirko Moreno Zaldivar, Katrin Pauels, Philipp von Hundelshausen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 7, 2017
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortalityJennifer M Lehmann, Karina Claus, Christian Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shuntMarie-Luise Berres, Jennifer Lehmann, Christian Jansen, et al.
Journal of Hepatology|December 15, 2007
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infectionHermann E Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, et al.
The American Journal of Pathology|November 13, 2012
Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosisIna V Martin, Erawan Borkham-Kamphorst, Stephanie Zok, et al.
Frontiers in Physiology|April 12, 2019
Platelet Factor 4 Attenuates Experimental Acute Liver Injury in MiceHannah K Drescher, Elisa F Brandt, Petra Fischer, et al.
Frontiers in Immunology|March 29, 2020
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in CirrhosisAlexander Queck, Hannah Bode, Frank E Uschner, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
The Journal of Clinical Investigation|October 28, 2010
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceMarie-Luise Berres, Rory R Koenen, Anna Rueland, et al.
Cells|February 2, 2021
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell PopulationsDaniel Heinrichs, Elisa F Brandt, Petra Fischer, et al.
Pageof 11

Showing results (91-100 of 104) with videos related to

Sort By:
Pageof 11
Hepatology (Baltimore, Md.)|February 18, 2010
CXC chemokine ligand 4 (Cxcl4) is a platelet-derived mediator of experimental liver fibrosisMirko Moreno Zaldivar, Katrin Pauels, Philipp von Hundelshausen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|November 7, 2017
Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortalityJennifer M Lehmann, Karina Claus, Christian Jansen, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|July 28, 2015
Chemokine (C-X-C motif) ligand 11 levels predict survival in cirrhotic patients with transjugular intrahepatic portosystemic shuntMarie-Luise Berres, Jennifer Lehmann, Christian Jansen, et al.
Journal of Hepatology|December 15, 2007
The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infectionHermann E Wasmuth, Mirko Moreno Zaldivar, Marie-Luise Berres, et al.
The American Journal of Pathology|November 13, 2012
Platelet-derived growth factor (PDGF)-C neutralization reveals differential roles of PDGF receptors in liver and kidney fibrosisIna V Martin, Erawan Borkham-Kamphorst, Stephanie Zok, et al.
Frontiers in Physiology|April 12, 2019
Platelet Factor 4 Attenuates Experimental Acute Liver Injury in MiceHannah K Drescher, Elisa F Brandt, Petra Fischer, et al.
Frontiers in Immunology|March 29, 2020
Systemic MCP-1 Levels Derive Mainly From Injured Liver and Are Associated With Complications in CirrhosisAlexander Queck, Hannah Bode, Frank E Uschner, et al.
Gut|January 24, 2012
Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancerCarlo Schneider, Andreas Teufel, Tetyana Yevsa, et al.
The Journal of Clinical Investigation|October 28, 2010
Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in miceMarie-Luise Berres, Rory R Koenen, Anna Rueland, et al.
Cells|February 2, 2021
Unexpected Pro-Fibrotic Effect of MIF in Non-Alcoholic Steatohepatitis Is Linked to a Shift in NKT Cell PopulationsDaniel Heinrichs, Elisa F Brandt, Petra Fischer, et al.
Pageof 11